On a global scale, emergency departments have been providing critical access to the health care system for many years, however, more recently visits to the emergency department has been an opportunity to identify patients with substance use disorders. Screening patients for illicit drugs and drug abuse has become increasingly more regular when a patient is admitted to the emergency department. Screening is vital to treat a patient with effective treatment. Nearly half of all emergency department visits in the US are categorized as relating to substance use disorders.
In a study completed at Ghent University Hospital in 2017 it was found that the most frequently reported drugs abused by emergency department patients are cannabis, cocaine, amphetamines, and opiates. It is important to screen patients in the emergency department if the patient is showing signs of confusion, deliriousness, unconsciousness, panic attacks, chest pain, difficulty breathing, vomiting, or seizures as these symptoms usually indicate drug intoxication or overdose.
Randox Toxicology’s Evidence MultiSTAT is a fully automated immunoanalyser that enables on-site simultaneous detection of up to 21 analytes from a single sample, making it ideal for an emergency department. It requires a small sample volume and generates results in 20 minutes. The process from sample entry to results can be completed in 3 simple steps, with minimum room for human error. The MultiSTAT is designed to analyse as quick, simple and reliable as possible.
|Barbiturates||Benzodiazepines I (Oxazepam)||Benzodiazepines II (Lorazepam)|
|Benzoylecgonine (Cocaine Metabolite)||Buprenorphine||Cannabinoids (THC)|
|Creatinine||Ethyl Glucuronide (EtG)||Fentanyl|
|Tricyclic Antidepressants (TCA)||UR-144/XLR-11||α-PVP (Flakka)|
Randox Toxicology Products and Services
Want to know more about Randox?
Contact us or visit our homepage to view more.